Patent reform back on agenda in China

China’s 13th National People’s Congress (NPC) is moving forward with a revised draft of patent law amendments that includes increased patent protection for innovative drugs. Consideration by the NPC is the final step before enacting the amendments.

The fate of IP reforms

Read the full 412 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE